Journal of Medicinal Chemistry, volume 61, issue 17, pages 7827-7848

2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction

Felicetti Tommaso 1
Cannalire Rolando 1
Lubelska Annamaria 2
Manfroni Giuseppe 1
Barreca Maria Letizia 1
Massari Serena 1
Tabarrini Oriana 1
Kieć-Kononowicz Katarzyna 2
Schindler Bryan D 3
Kaatz Glenn W. 3
Cecchetti Violetta 1
Sabatini Stefano 1
2
 
Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University-Medical College, ul. Medyczna 9, 31-688 Cracow, Poland
3
 
John D. Dingell Department of Veterans Affairs Medical Centre and the Department of Internal Medicine, Division of Infectious Diseases, School of Medicine, Wayne State University, Detroit, Michigan 48201, United States
Publication typeJournal Article
Publication date2018-08-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor7.3
ISSN00222623, 15204804
Drug Discovery
Molecular Medicine
Abstract
Antimicrobial resistance (AMR) represents a hot topic in drug discovery. Besides the identification of new antibiotics, the use of nonantibiotic molecules to block resistance mechanisms is a powerful alternative. Bacterial efflux pumps exert an early step in AMR development by allowing bacteria to grow at subinhibitorial drug concentrations. Thus, efflux pump inhibitors (EPIs) offer a great opportunity to fight AMR. Given our experience in developing Staphylococcus aureus NorA EPIs, in this work, starting from the 2-phenylquinoline hit 1, we planned the introduction of methoxy groups on the basis of their presence in known NorA EPIs. Among the 35 different synthesized derivatives, compounds 3b and 7d exhibited the best NorA inhibition activity by restoring at very low concentrations ciprofloxacin MICs against resistant S. aureus strains. Interestingly, both compounds displayed EPI activities at nontoxic concentrations for human cells as well as highlighted promising results by preliminary pharmacokinetic studies.

Citations by journals

1
2
3
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 3, 7.14%
European Journal of Medicinal Chemistry
3 publications, 7.14%
Journal of Molecular Structure
Journal of Molecular Structure, 3, 7.14%
Journal of Molecular Structure
3 publications, 7.14%
Current Topics in Medicinal Chemistry
Current Topics in Medicinal Chemistry, 2, 4.76%
Current Topics in Medicinal Chemistry
2 publications, 4.76%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2, 4.76%
International Journal of Molecular Sciences
2 publications, 4.76%
Molecules
Molecules, 2, 4.76%
Molecules
2 publications, 4.76%
Antibiotics
Antibiotics, 2, 4.76%
Antibiotics
2 publications, 4.76%
Microbial Pathogenesis
Microbial Pathogenesis, 2, 4.76%
Microbial Pathogenesis
2 publications, 4.76%
Green Chemistry
Green Chemistry, 2, 4.76%
Green Chemistry
2 publications, 4.76%
Combinatorial Chemistry and High Throughput Screening
Combinatorial Chemistry and High Throughput Screening, 1, 2.38%
Combinatorial Chemistry and High Throughput Screening
1 publication, 2.38%
Beilstein Journal of Organic Chemistry
Beilstein Journal of Organic Chemistry, 1, 2.38%
Beilstein Journal of Organic Chemistry
1 publication, 2.38%
Frontiers in Microbiology
Frontiers in Microbiology, 1, 2.38%
Frontiers in Microbiology
1 publication, 2.38%
Scientific Reports
Scientific Reports, 1, 2.38%
Scientific Reports
1 publication, 2.38%
Pharmaceutics
Pharmaceutics, 1, 2.38%
Pharmaceutics
1 publication, 2.38%
Chemical Engineering Science
Chemical Engineering Science, 1, 2.38%
Chemical Engineering Science
1 publication, 2.38%
Environmental International
Environmental International, 1, 2.38%
Environmental International
1 publication, 2.38%
European Journal of Pharmaceutical Sciences
European Journal of Pharmaceutical Sciences, 1, 2.38%
European Journal of Pharmaceutical Sciences
1 publication, 2.38%
Journal of Global Antimicrobial Resistance
Journal of Global Antimicrobial Resistance, 1, 2.38%
Journal of Global Antimicrobial Resistance
1 publication, 2.38%
Medicinal Research Reviews
Medicinal Research Reviews, 1, 2.38%
Medicinal Research Reviews
1 publication, 2.38%
ChemMedChem
ChemMedChem, 1, 2.38%
ChemMedChem
1 publication, 2.38%
ACS Infectious Diseases
ACS Infectious Diseases, 1, 2.38%
ACS Infectious Diseases
1 publication, 2.38%
Journal of the American Chemical Society
Journal of the American Chemical Society, 1, 2.38%
Journal of the American Chemical Society
1 publication, 2.38%
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, 1, 2.38%
Journal of Medicinal Chemistry
1 publication, 2.38%
ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters, 1, 2.38%
ACS Medicinal Chemistry Letters
1 publication, 2.38%
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 1, 2.38%
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
1 publication, 2.38%
Drug Delivery
Drug Delivery, 1, 2.38%
Drug Delivery
1 publication, 2.38%
Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry, 1, 2.38%
Journal of Enzyme Inhibition and Medicinal Chemistry
1 publication, 2.38%
Tissue Barriers
Tissue Barriers, 1, 2.38%
Tissue Barriers
1 publication, 2.38%
Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, 1, 2.38%
Journal of Antimicrobial Chemotherapy
1 publication, 2.38%
Journal of Chemical Information and Modeling
Journal of Chemical Information and Modeling, 1, 2.38%
Journal of Chemical Information and Modeling
1 publication, 2.38%
1
2
3

Citations by publishers

2
4
6
8
10
12
14
Elsevier
Elsevier, 14, 33.33%
Elsevier
14 publications, 33.33%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 7, 16.67%
Multidisciplinary Digital Publishing Institute (MDPI)
7 publications, 16.67%
American Chemical Society (ACS)
American Chemical Society (ACS), 5, 11.9%
American Chemical Society (ACS)
5 publications, 11.9%
Taylor & Francis
Taylor & Francis, 4, 9.52%
Taylor & Francis
4 publications, 9.52%
Bentham Science
Bentham Science, 3, 7.14%
Bentham Science
3 publications, 7.14%
Wiley
Wiley, 2, 4.76%
Wiley
2 publications, 4.76%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 2, 4.76%
Royal Society of Chemistry (RSC)
2 publications, 4.76%
Beilstein-Institut
Beilstein-Institut, 1, 2.38%
Beilstein-Institut
1 publication, 2.38%
Frontiers Media S.A.
Frontiers Media S.A., 1, 2.38%
Frontiers Media S.A.
1 publication, 2.38%
Springer Nature
Springer Nature, 1, 2.38%
Springer Nature
1 publication, 2.38%
Oxford University Press
Oxford University Press, 1, 2.38%
Oxford University Press
1 publication, 2.38%
2
4
6
8
10
12
14
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Felicetti T. et al. 2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction // Journal of Medicinal Chemistry. 2018. Vol. 61. No. 17. pp. 7827-7848.
GOST all authors (up to 50) Copy
Felicetti T., Cannalire R., Pietrella D., Latacz G., Lubelska A., Manfroni G., Barreca M. L., Massari S., Tabarrini O., Kieć-Kononowicz K., Schindler B. D., Kaatz G. W., Cecchetti V., Sabatini S. 2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction // Journal of Medicinal Chemistry. 2018. Vol. 61. No. 17. pp. 7827-7848.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/acs.jmedchem.8b00791
UR - https://doi.org/10.1021%2Facs.jmedchem.8b00791
TI - 2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction
T2 - Journal of Medicinal Chemistry
AU - Schindler, Bryan D
AU - Felicetti, Tommaso
AU - Cannalire, Rolando
AU - Manfroni, Giuseppe
AU - Barreca, Maria Letizia
AU - Sabatini, Stefano
AU - Pietrella, Donatella
AU - Latacz, Gniewomir
AU - Lubelska, Annamaria
AU - Massari, Serena
AU - Tabarrini, Oriana
AU - Kieć-Kononowicz, Katarzyna
AU - Kaatz, Glenn W.
AU - Cecchetti, Violetta
PY - 2018
DA - 2018/08/01 00:00:00
PB - American Chemical Society (ACS)
SP - 7827-7848
IS - 17
VL - 61
SN - 0022-2623
SN - 1520-4804
ER -
BibTex |
Cite this
BibTex Copy
@article{2018_Felicetti,
author = {Bryan D Schindler and Tommaso Felicetti and Rolando Cannalire and Giuseppe Manfroni and Maria Letizia Barreca and Stefano Sabatini and Donatella Pietrella and Gniewomir Latacz and Annamaria Lubelska and Serena Massari and Oriana Tabarrini and Katarzyna Kieć-Kononowicz and Glenn W. Kaatz and Violetta Cecchetti},
title = {2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction},
journal = {Journal of Medicinal Chemistry},
year = {2018},
volume = {61},
publisher = {American Chemical Society (ACS)},
month = {aug},
url = {https://doi.org/10.1021%2Facs.jmedchem.8b00791},
number = {17},
pages = {7827--7848},
doi = {10.1021/acs.jmedchem.8b00791}
}
MLA
Cite this
MLA Copy
Felicetti, Tommaso, et al. “2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.” Journal of Medicinal Chemistry, vol. 61, no. 17, Aug. 2018, pp. 7827-7848. https://doi.org/10.1021%2Facs.jmedchem.8b00791.
Found error?